John Otrompke
Published Online: 5:50 PM, Wed January 27, 2016
"Patients on the control arm could crossover to get evofosfamide once they had progressed. This confounded the survival results in the phase II (ie, the control arm performed better with the patients who subsequently got evofosfamide). There was no crossover in the Phase III."
...